Pilot Trial of Hyper-CVAD and Methotrexate/ARA C Plus Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Antineoplastics; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Folinic acid; Methotrexate; Rituximab; Vincristine
- Indications Mantle-cell lymphoma
- Focus Therapeutic Use
- 01 Nov 2012 Biomarkers information updated
- 17 Jun 2011 Additional lead trial center (Southwest Oncology Group) added as reported by ClinicalTrials.gov.
- 09 Oct 2006 Status change